Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
9 Months Ended |
May 31, 2021 |
May 31, 2020 |
| Cash flows from operating activities: |
|
|
| Net income (loss) |
$ 304,683
|
$ 401,932
|
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
| Depreciation and amortization |
401,657
|
408,613
|
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions |
(128,635)
|
1,339
|
| Provision for doubtful accounts |
3,353
|
7,692
|
| Deferred taxes |
17,379
|
(11,811)
|
| Other, net |
(24,420)
|
67,625
|
| Changes in operating assets and liabilities, net of acquisitions: |
|
|
| Receivables |
(885,496)
|
25,290
|
| Inventories |
(763,675)
|
(5,602)
|
| Accounts payable and accrued expenses |
775,825
|
(185,503)
|
| Other liabilities |
(333,049)
|
(183,732)
|
| Net cash provided by (used in) operating activities |
(632,378)
|
525,843
|
| Cash flows from investing activities: |
|
|
| Acquisition of property, plant and equipment |
(238,774)
|
(316,506)
|
| Proceeds from disposition of property, plant and equipment |
17,039
|
28,257
|
| Expenditures for major repairs |
(42,466)
|
(10,414)
|
| Proceeds from Sales of Business, Affiliate and Productive Assets |
39,567
|
694
|
| Changes in CHS Capital notes receivable, net |
31,543
|
219,173
|
| Financing extended to customers |
(1,890)
|
(5,139)
|
| Payments from customer financing |
6,110
|
21,341
|
| Other investing activities, net |
11,362
|
14,061
|
| Net cash provided by (used in) investing activities |
(177,509)
|
(48,533)
|
| Cash flows from financing activities: |
|
|
| Proceeds from lines of credit and long-term borrowings |
26,618,429
|
19,841,762
|
| Payments on lines of credit, long-term borrowings and capital lease obligations |
(25,381,437)
|
(19,805,609)
|
| Preferred stock dividends paid |
(126,501)
|
(126,501)
|
| Redemptions of equities |
(37,809)
|
(86,272)
|
| Cash patronage dividends paid |
(30,042)
|
(90,112)
|
| Other financing activities, net |
(30,634)
|
(25,475)
|
| Net cash provided by (used in) financing activities |
1,012,006
|
(292,207)
|
| Effect of exchange rate changes on cash and cash equivalents |
(451)
|
(786)
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
201,668
|
184,317
|
| Cash and cash equivalents and restricted cash at beginning of period |
216,993
|
299,675
|
| Cash and cash equivalents and restricted cash at end of period |
$ 418,661
|
$ 483,992
|